These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 3945450

  • 1. Serum relaxin in patients with hydatidiform mole.
    Seki K, Uesato T, Tabei T, Kato K.
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [Abstract] [Full Text] [Related]

  • 2. Plasma human chorionic gonadotropin disappearance in hydatidiform mole: a central registry report from the Netherlands.
    Franke HR, Risse EK, Kenemans P, Houx PC, Stolk JG, Vooijs GP.
    Obstet Gynecol; 1983 Oct; 62(4):467-73. PubMed ID: 6888825
    [Abstract] [Full Text] [Related]

  • 3. Serum relaxin in patients with invasive mole, choriocarcinoma and persistent trophoblastic disease.
    Seki K, Uesato T, Kato K.
    Endocrinol Jpn; 1986 Oct; 33(5):727-33. PubMed ID: 3030714
    [Abstract] [Full Text] [Related]

  • 4. Hydatidiform mole and post-evacuation regression patterns of serum beta human chorionic gonadotrophin.
    Kamariah K, Satgunasingam N, Nasri NM, Ng KY.
    Med J Malaysia; 1993 Mar; 48(1):40-5. PubMed ID: 7688063
    [Abstract] [Full Text] [Related]

  • 5. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 6. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 7. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation.
    Ho PC, Wong LC, Ma HK.
    Obstet Gynecol; 1986 Jan; 67(1):99-106. PubMed ID: 3940346
    [Abstract] [Full Text] [Related]

  • 8. Pre-evacuation hCG glycoforms in uneventful complete hydatidiform mole and persistent trophoblastic disease.
    Thomas CM, Kerkmeijer LG, Ariaens HJ, van der Steen RC, Massuger LF, Sweep FC.
    Gynecol Oncol; 2010 Apr; 117(1):47-52. PubMed ID: 20116088
    [Abstract] [Full Text] [Related]

  • 9. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA, Schlaerth JB, Ahn C, Sauer MV.
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI, Kacinski BM, Stanley ER.
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [Abstract] [Full Text] [Related]

  • 11. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 12. An unusual clinical course after mole evacuation: a case report.
    Okamoto T, Nakanishi T, Nomura S, Goto S, Sakaida H, Tomoda Y.
    Nagoya J Med Sci; 1997 Mar; 60(1-2):49-52. PubMed ID: 9212649
    [Abstract] [Full Text] [Related]

  • 13. [Changes in serum human chorionic gonadotropin in patients with hydatidiform mole following evacuation].
    Wang X.
    Zhonghua Fu Chan Ke Za Zhi; 1988 Nov; 23(6):362-4, 388. PubMed ID: 2854773
    [No Abstract] [Full Text] [Related]

  • 14. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G, Pürstner P.
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
    [Abstract] [Full Text] [Related]

  • 15. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E.
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [Abstract] [Full Text] [Related]

  • 16. [Partial hydatidiform mole with significantly increased serum HCG levels in the triploidy syndrome].
    Arnholdt H, Elser H, Dörmer P.
    Geburtshilfe Frauenheilkd; 1984 May; 44(5):328-32. PubMed ID: 6565615
    [Abstract] [Full Text] [Related]

  • 17. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R, Ozturk M, Goldstein D, Bernstein M, Hill L, Wands JR.
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [Abstract] [Full Text] [Related]

  • 18. Persistence of gestational trophoblastic disease for longer than 1 year following evacuation of hydatidiform mole.
    Elmer DB, Granai CO, Ball HG, Curry SL.
    Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):888-90. PubMed ID: 7682320
    [Abstract] [Full Text] [Related]

  • 19. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
    Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E.
    Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
    [Abstract] [Full Text] [Related]

  • 20. Evidence for the luteal source of circulating relaxin in molar pregnancy.
    Seki K, Kato K.
    Acta Obstet Gynecol Scand; 1987 Sep; 66(4):319-20. PubMed ID: 3425229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.